Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
Published on: April 5, 2024
"Techquity" in Pediatric, Adolescent, and Young Adult Oncology: Addressing Inequities Through Artificial Intelligence
Vidya Puthenpura1, Mary Hunter2, Asher M Marks1
1Section of Pediatric Hematology and Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Abstract:
Health disparities in pediatric, adolescent, and young adult (AYA) oncology remain a significant challenge, with socioeconomic status, geographic location, race, and ethnicity contributing to unequal access to care and poorer outcomes. Emerging technologies, including artificial intelligence (AI) and immersive tools such as virtual and augmented reality (VR/AR), offer transformative solutions to address these inequities. AI has demonstrated potential in enhancing diagnostic accuracy, tailoring treatment plans, and providing personalized patient navigation to guide families through complex care pathways. Immersive technologies have shown promise in delivering equitable, supportive care, including VR-based psychological support, pain management, physical rehabilitation, and patient education. This paper explores how integrating AI and immersive technology tools into cancer care can enhance quality of life and bridge gaps in care delivery for pediatric and AYA patients. Additionally, the increasing availability of internet-enabled devices presents an unprecedented opportunity to overcome traditional barriers to care in underserved populations. The paper also addresses critical challenges, including the digital divide, ethical considerations, and cost barriers, while proposing strategies for equitable implementation. By leveraging these technologies, healthcare providers can create more inclusive and effective treatment environments, ensuring that the benefits of innovation reach all patients, regardless of background or circumstance.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...

